EyeYon Medical Ltd. Receives FDA IDE Approval to Initiate US Clinical Study of EndoArt®, the First Artificial Endothelial Layer for Corneal Edema

EyeYon Medical Ltd. announced that the US FDA has granted Investigational Device Exemption (IDE) approval to initiate a US clinical study of EndoArt^®, the world’s first synthetic endothelial layer for the treatment of chronic corneal edema.